Magnetic resonance-guided radiation therapy: A review
- PMID: 31646742
- DOI: 10.1111/1754-9485.12968
Magnetic resonance-guided radiation therapy: A review
Abstract
Magnetic resonance-guided radiation therapy (MRgRT) is a promising approach to improving clinical outcomes for patients treated with radiation therapy. The roles of image guidance, adaptive planning and magnetic resonance imaging in radiation therapy have been increasing over the last two decades. Technical advances have led to the feasible combination of magnetic resonance imaging and radiation therapy technologies, leading to improved soft-tissue visualisation, assessment of inter- and intrafraction motion, motion management, online adaptive radiation therapy and the incorporation of functional information into treatment. MRgRT can potentially transform radiation oncology by improving tumour control and quality of life after radiation therapy and increasing convenience of treatment by shortening treatment courses for patients. Multiple groups have developed clinical implementations of MRgRT predominantly in the abdomen and pelvis, with patients having been treated since 2014. While studies of MRgRT have primarily been dosimetric so far, an increasing number of trials are underway examining the potential clinical benefits of MRgRT, with coordinated efforts to rigorously evaluate the benefits of the promising technology. This review discusses the current implementations, studies, potential benefits and challenges of MRgRT.
Keywords: MR-guided radiation therapy; magnetic resonance imaging; radiation oncology; radiation oncology imaging.
© 2019 The Royal Australian and New Zealand College of Radiologists.
References
-
- de Crevoisier R, Bayar MA, Pommier P et al. Daily versus weekly prostate cancer image guided radiation therapy: phase 3 multicenter randomized trial. Int J Radiat Oncol Biol Phys 2018; 102: 1420-9.
-
- Tøndel H, Lund J-Å, Lydersen S et al. Radiotherapy for prostate cancer - does daily image guidance with tighter margins improve patient reported outcomes compared to weekly orthogonal verified irradiation? Results from a randomized controlled trial. Radiother Oncol 2018; 126: 229-35.
-
- Njeh CF, Dong L, Orton CG. Point/Counterpoint. IGRT has limited clinical value due to lack of accurate tumor delineation. Med Phys 2013; 40: 040601.
-
- Guckenberger M, Wilbert J, Richter A, Baier K, Flentje M. Potential of adaptive radiotherapy to escalate the radiation dose in combined radiochemotherapy for locally advanced non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2011; 79: 901-8.
-
- Foroudi F, Wong J, Kron T et al. Online adaptive radiotherapy for muscle-invasive bladder cancer: results of a pilot study. Int J Radiat Oncol Biol Phys 2011; 81: 765-71.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical